No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs572012586 |
chr2:100935957-100935958 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs531246456 |
chr2:100935965-100935966 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs111852934 |
chr2:100935985-100935986 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs567867273 |
chr2:100936100-100936101 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs535930108 |
chr2:100936104-100936105 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs13391540 |
chr2:100936124-100936125 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs189130350 |
chr2:100936162-100936163 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs115565695 |
chr2:100936165-100936166 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs558419040 |
chr2:100936168-100936169 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs181543334 |
chr2:100936175-100936176 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs185808555 |
chr2:100936202-100936203 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs11123826 |
chr2:100936276-100936277 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
13 |
rs574610128 |
chr2:100936319-100936320 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs73968812 |
chr2:100936357-100936358 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs75152355 |
chr2:100936369-100936370 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs528487348 |
chr2:100936432-100936433 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs553995110 |
chr2:100936502-100936503 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs565285564 |
chr2:100936544-100936545 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs143047442 |
chr2:100936550-100936551 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs11694700 |
chr2:100936637-100936638 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs551270214 |
chr2:100936691-100936692 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs572467643 |
chr2:100936701-100936702 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs567740834 |
chr2:100936716-100936717 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs148377774 |
chr2:100936808-100936809 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs368031540 |
chr2:100936815-100936816 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs115547337 |
chr2:100936941-100936942 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs371549323 |
chr2:100936948-100936949 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs34160005 |
chr2:100936964-100936965 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs538355232 |
chr2:100936980-100936981 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs551709287 |
chr2:100937002-100937003 |
Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs568856819 |
chr2:100937013-100937014 |
Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs537734542 |
chr2:100937062-100937063 |
Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs536259779 |
chr2:100937085-100937086 |
Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs182720420 |
chr2:100937094-100937095 |
Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs574545267 |
chr2:100937131-100937132 |
Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs114766847 |
chr2:100937182-100937183 |
Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs141601340 |
chr2:100937185-100937186 |
Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs573328924 |
chr2:100937215-100937216 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs371904246 |
chr2:100937280-100937281 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs145889824 |
chr2:100937299-100937300 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs575626120 |
chr2:100937311-100937312 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs138443005 |
chr2:100937327-100937328 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs554900714 |
chr2:100937332-100937333 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs7582424 |
chr2:100937407-100937408 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs374381953 |
chr2:100937435-100937436 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs546749275 |
chr2:100937444-100937445 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs560316200 |
chr2:100937451-100937452 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs532049216 |
chr2:100937459-100937460 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs576356379 |
chr2:100937465-100937466 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs540418345 |
chr2:100937467-100937468 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|